BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26103027)

  • 1. Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction.
    Pokorney SD; Miller AL; Chen AY; Thomas L; Fonarow GC; de Lemos JA; Al-Khatib SM; Peterson ED; Wang TY
    JAMA; 2015 Jun 23-30; 313(24):2433-40. PubMed ID: 26103027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction.
    Pokorney SD; Miller AL; Chen AY; Thomas L; Fonarow GC; de Lemos JA; Al-Khatib SM; Velazquez EJ; Peterson ED; Wang TY
    Circulation; 2017 Jan; 135(1):38-47. PubMed ID: 27881561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥65 Years of Age With a Low Ejection Fraction After Coronary Revascularization.
    Goldstein SA; Li S; Lu D; Matsouaka RA; Rymer J; Fonarow GC; de Lemos JA; Peterson E; Pokorney SD; Wang T; Al-Khatib SM
    Am J Cardiol; 2021 Jan; 138():26-32. PubMed ID: 33068540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate?
    Liang JJ; Hodge DO; Mehta RA; Russo AM; Prasad A; Cha YM
    Europace; 2014 Dec; 16(12):1759-66. PubMed ID: 25100756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
    Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Post-Discharge Risks in Older Survivors of Myocardial Infarction With and Without Out-of-Hospital Cardiac Arrest.
    Fordyce CB; Wang TY; Chen AY; Thomas L; Granger CB; Scirica BM; Henry TD; Wong GC; Ramanathan K; Hansen CM; Kragholm K; Peterson ED; Anderson ML
    J Am Coll Cardiol; 2016 May; 67(17):1981-90. PubMed ID: 27126525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator therapy in patients with ventricular fibrillation out of hospital cardiac arrest secondary to acute coronary syndrome.
    Madhavan M; Friedman PA; Lennon RJ; Prasad A; White RD; Sriram CS; Gulati R; Gersh BJ
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25713292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death.
    Curtis LH; Al-Khatib SM; Shea AM; Hammill BG; Hernandez AF; Schulman KA
    JAMA; 2007 Oct; 298(13):1517-24. PubMed ID: 17911496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insufficient compliance with current implantable cardioverter defibrillator (ICD) therapy guidelines in post myocardial infarction patients is associated with increased mortality.
    Pertzov B; Novack V; Zahger D; Katz A; Amit G
    Int J Cardiol; 2013 Jun; 166(2):421-4. PubMed ID: 22100182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.
    Chen CY; Stevenson LW; Stewart GC; Bhatt DL; Desai M; Seeger JD; Williams L; Jalbert JJ; Setoguchi S
    BMJ; 2015 Jul; 351():h3529. PubMed ID: 26174233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced ejection fraction after myocardial infarction: is it sufficient to justify implantation of a defibrillator?
    Pascale P; Taffe P; Regamey C; Kappenberger L; Fromer M
    Chest; 2005 Oct; 128(4):2626-32. PubMed ID: 16236935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Elapsed Time from Myocardial Infarction on Mortality and Major Adverse Cardiac and Cerebrovascular Events in ICD Patients.
    Bons LR; Dabiri-Abkenari L; VAN Domburg RT; Szili-Torok T; Zijlstra F; Theuns DA
    Pacing Clin Electrophysiol; 2015 Dec; 38(12):1448-55. PubMed ID: 26289034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eligibility and utilization of implantable cardioverter-defibrillators in a regional STEMI system.
    Johnson BK; Garberich RF; Henry TD; Katsiyiannis WT; Sengupta J; Kalra A; Hauser RG; Lardy ME; Newell MC
    Heart Rhythm; 2016 Feb; 13(2):538-46. PubMed ID: 26576706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database.
    MacFadden DR; Crystal E; Krahn AD; Mangat I; Healey JS; Dorian P; Birnie D; Simpson CS; Khaykin Y; Pinter A; Nanthakumar K; Calzavara AJ; Austin PC; Tu JV; Lee DS
    Ann Intern Med; 2012 Feb; 156(3):195-203. PubMed ID: 22312139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An "aggressive" protocol of programmed ventricular stimulation for selecting post-myocardial infarction patients with a low ejection fraction who may not require implantation of an automatic defibrillator.
    Belhassen B; Ohayon-Tsioni T; Glick A; Viskin S
    Isr Med Assoc J; 2009 Sep; 11(9):520-4, 526, 528. PubMed ID: 19960844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI study.
    Atary JZ; Borleffs CJ; Liem SS; Bax JJ; van der Hoeven BL; Bootsma M; van der Wall EE; van Erven L; Schalij MJ
    Europace; 2010 Mar; 12(3):378-84. PubMed ID: 20056593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure.
    Hernandez AF; Fonarow GC; Hammill BG; Al-Khatib SM; Yancy CW; O'Connor CM; Schulman KA; Peterson ED; Curtis LH
    Circ Heart Fail; 2010 Jan; 3(1):7-13. PubMed ID: 20009044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QRS complex widening as a predictor of appropriate implantable cardioverter-defibrillator (ICD) therapy and higher mortality risk in primary prevention ICD patients.
    Maciąg A; Przybylski A; Sterliński M; Lewandowski M; Gepner K; Kowalik I; Derejko P; Pytkowski M; Szumowski L; Szwed H
    Kardiol Pol; 2012; 70(4):360-8. PubMed ID: 22528709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.